{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T11:59:02Z","timestamp":1790510342395,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,23]],"date-time":"2019-04-23T00:00:00Z","timestamp":1555977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,4,23]],"date-time":"2019-04-23T00:00:00Z","timestamp":1555977600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"La r&amp;#x00E9;gion Picardie"},{"name":"La r&amp;#x00E9;gion Hauts-de-France"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Ischemic stroke is highly prevalent in chronic kidney disease (CKD) patients and has been associated with a higher risk of neurological deterioration and in-hospital mortality. To date, little is known about the processes by which CKD worsens ischemic stroke. This work aimed to investigate the cellular and molecular mechanism associated with ischemic stroke severity in an <jats:italic>in vivo<\/jats:italic> model of CKD. CKD was induced through right kidney cortical electrocautery in 8-week-old female C57BL\/6\u2009J mice followed by left total nephrectomy. Transient middle cerebral artery occlusion (tMCAO) was performed 6 weeks after left nephrectomy. Twenty-four hours after tMCAO, the infarct volumes were significantly wider in CKD than in SHAM mice. CKD mice displayed decreased neuroscore, impaired ability to remain on rotarod device, weaker muscular strength and decreased prehensile score. Apoptosis, neuronal loss, glial cells recruitment and microglia\/macrophages M<jats:sub>1<\/jats:sub> signature genes CD32, CD86, IL-1\u03b2, IL-6, MCP1 and iNOS were significantly increased within ischemic lesions of CKD mice. This effect was associated with decreased AMP kinase phosphorylation and increased activation of the NF\u039aB pathway. Pharmacological targeting of AMP kinase activity, which is known to block microglia\/macrophages M<jats:sub>1<\/jats:sub> polarization, appears promising to improve stroke recovery in CKD.<\/jats:p>","DOI":"10.1038\/s41598-019-42933-0","type":"journal-article","created":{"date-parts":[[2019,4,23]],"date-time":"2019-04-23T10:03:39Z","timestamp":1556013819000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Cellular and molecular mechanisms associated with ischemic stroke severity in female mice with chronic kidney disease"],"prefix":"10.1038","volume":"9","author":[{"given":"Lucie","family":"H\u00e9naut","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Grissi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3898-4389","authenticated-orcid":false,"given":"Fran\u00e7ois","family":"Brazier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Assem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Poirot-Leclercq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ga\u00eblle","family":"Lenglet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9dric","family":"Boudot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9310-7840","authenticated-orcid":false,"given":"Carine","family":"Avondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agn\u00e8s","family":"Boullier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Choukroun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziad. A","family":"Massy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sa\u00efd","family":"Kamel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marc","family":"Chillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,23]]},"reference":[{"key":"42933_CR1","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1053\/j.ajkd.2009.01.261","volume":"54","author":"SM Sozio","year":"2009","unstructured":"Sozio, S. M. et al. Cerebrovascular disease incidence, characteristics, and outcomes in patients initiating dialysis: the choices for healthy outcomes in caring for ESRD (CHOICE) study. Am J Kidney Dis. 54, 468\u2013477 (2009).","journal-title":"Am J Kidney Dis."},{"key":"42933_CR2","doi-asserted-by":"publisher","first-page":"80","DOI":"10.2215\/CJN.02900314","volume":"10","author":"JB Wetmore","year":"2015","unstructured":"Wetmore, J. B. et al. Relationship between stroke and mortality in dialysis patients. Clin J Am Soc Nephrol. 10, 80\u201389 (2015).","journal-title":"Clin J Am Soc Nephrol."},{"key":"42933_CR3","doi-asserted-by":"publisher","first-page":"607","DOI":"10.3109\/07853890.2011.582136","volume":"44","author":"MJ Holzmann","year":"2012","unstructured":"Holzmann, M. J. et al. Renal dysfunction increases the risk of ischemic and hemorrhagic stroke in the general population. Ann Med. 44, 607\u2013615 (2012).","journal-title":"Ann Med."},{"key":"42933_CR4","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1212\/WNL.0b013e318259e110","volume":"78","author":"Y Kumai","year":"2012","unstructured":"Kumai, Y. et al. Proteinuria and clinical outcomes after ischemic stroke. Neurology. 78, 1909\u20131915 (2012).","journal-title":"Neurology."},{"key":"42933_CR5","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.3389\/fphys.2018.01726","volume":"9","author":"H Qiu","year":"2018","unstructured":"Qiu, H. et al. Chronic Kidney Disease Increases Atrial Fibrillation Inducibility: Involvement of Inflammation, Atrial Fibrosis, and Connexins. Front Physiol. 9, 1726 (2018).","journal-title":"Front Physiol."},{"key":"42933_CR6","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.2215\/CJN.04060318","volume":"13","author":"JJ Carrero","year":"2018","unstructured":"Carrero, J. J. et al. Incident Atrial Fibrillation and the Risk of Stroke in Adults with Chronic Kidney Disease: The Stockholm CREAtinine Measurements (SCREAM) Project. Clin J Am Soc Nephrol. 13, 1314\u20131320 (2018).","journal-title":"Clin J Am Soc Nephrol."},{"key":"42933_CR7","doi-asserted-by":"publisher","first-page":"c4249","DOI":"10.1136\/bmj.c4249","volume":"341","author":"M Lee","year":"2010","unstructured":"Lee, M. et al. Low glomerular filtration rate and risk of stroke: meta-analysis. BMJ. 341, c4249 (2010).","journal-title":"BMJ."},{"issue":"7","key":"42933_CR8","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3390\/toxins10070303","volume":"10","author":"Maryam Assem","year":"2018","unstructured":"Assem, M. et al. The Impact of Uremic Toxins on Cerebrovascular and Cognitive Disorders. Toxins (Basel). 10 (2018).","journal-title":"Toxins"},{"key":"42933_CR9","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1053\/j.jvca.2012.06.012","volume":"27","author":"RB Yates","year":"2013","unstructured":"Yates, R. B. et al. Lack of evidence for a remote effect of renal ischemia\/reperfusion acute kidney injury on outcome from temporary focal cerebral ischemia in the rat. J Cardiothorac Vasc Anesth. 27, 71\u201378 (2013).","journal-title":"J Cardiothorac Vasc Anesth."},{"key":"42933_CR10","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1681\/ASN.2004060495","volume":"16","author":"ZA Massy","year":"2005","unstructured":"Massy, Z. A. et al. Uremia accelerates both atherosclerosis and arterial calcification in apolipoprotein E knockout mice. J Am Soc Nephrol. 16, 109\u2013116 (2005).","journal-title":"J Am Soc Nephrol."},{"key":"42933_CR11","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/S0006-8993(00)02100-4","volume":"863","author":"S Zausinger","year":"2000","unstructured":"Zausinger, S., Hungerhuber, E., Baethmann, A., Reulen, H. & Schmid-Elsaesser, R. Neurological impairment in rats after transient middle cerebral artery occlusion: a comparative study under various treatment paradigms. Brain Res. 863, 94\u2013105 (2000).","journal-title":"Brain Res."},{"key":"42933_CR12","unstructured":"Paxinos, G., Franklin, K. The Mouse Brain In Stereotaxic Coordinates 4th Edition (ed. Academic Press) 1\u2013360 (2012)."},{"key":"42933_CR13","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1097\/00004647-200008000-00004","volume":"20","author":"R Bordet","year":"2000","unstructured":"Bordet, R. et al. Increase in endogenous brain superoxide dismutase as a potential mechanism of lipopolysaccharide-induced brain ischemic tolerance. J Cereb Blood Flow Metab. 20, 1190\u20131196 (2000).","journal-title":"J Cereb Blood Flow Metab."},{"key":"42933_CR14","doi-asserted-by":"publisher","first-page":"8633","DOI":"10.4049\/jimmunol.181.12.8633","volume":"181","author":"D Sag","year":"2008","unstructured":"Sag, D., Carling, D., Stout, R. D. & Suttles, J. Adenosine 5\u2032-monophosphate-activated protein kinase promotes macrophage polarization to an anti-inflammatory functional phenotype. J Immunol. 181, 8633\u20138641 (2008).","journal-title":"J Immunol."},{"key":"42933_CR15","first-page":"692061","volume":"2014","author":"CC Chen","year":"2014","unstructured":"Chen, C. C. et al. Amelioration of LPS-induced inflammation response in microglia by AMPK activation. Biomed Res Int. 2014, 692061 (2014).","journal-title":"Biomed Res Int."},{"key":"42933_CR16","doi-asserted-by":"crossref","unstructured":"Yang, Z., Kahn, B. B., Shi, H., Xue, B. Z. Macrophage alpha1 AMP-activated protein kinase (alpha1AMPK) antagonizes fatty acid-induced inflammation through SIRT1. J Biol Chem. 285, 19051-19059 (2010).","DOI":"10.1074\/jbc.M110.123620"},{"key":"42933_CR17","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1006\/smim.2000.0210","volume":"12","author":"M Karin","year":"2000","unstructured":"Karin, M. & Delhase, M. The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signalling. Semin Immunol. 12, 85\u201398 (2000).","journal-title":"Semin Immunol."},{"key":"42933_CR18","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1093\/cvr\/cvs240","volume":"96","author":"I Six","year":"2012","unstructured":"Six, I. et al. Effects of phosphate on vascular function under normal conditions and influence of the uraemic state. Cardiovasc Res. 96, 130\u2013139 (2012).","journal-title":"Cardiovasc Res."},{"key":"42933_CR19","doi-asserted-by":"publisher","first-page":"960","DOI":"10.5551\/jat.34462","volume":"23","author":"S Ito","year":"2016","unstructured":"Ito, S., Osaka, M., Edamatsu, T., Itoh, Y. & Yoshida, M. Crucial Role of the Aryl Hydrocarbon Receptor (AhR) in Indoxyl Sulfate-Induced Vascular Inflammation. J Atheroscler Thromb. 23, 960\u2013975 (2016).","journal-title":"J Atheroscler Thromb."},{"key":"42933_CR20","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1189\/jlb.0112023","volume":"93","author":"S Ito","year":"2013","unstructured":"Ito, S. et al. Reduction of indoxyl sulfate by AST-120 attenuates monocyte inflammation related to chronic kidney disease. J Leukoc Biol. 93, 837\u2013845 (2013).","journal-title":"J Leukoc Biol."},{"key":"42933_CR21","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/nrn1870","volume":"7","author":"G Seifert","year":"2006","unstructured":"Seifert, G., Schilling, K. & Steinh\u00e4user, C. Astrocyte dysfunction in neurological disorders: a molecular perspective. Nat Rev Neurosci. 7, 194\u2013206 (2006).","journal-title":"Nat Rev Neurosci."},{"key":"42933_CR22","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3390\/ijms17030288","volume":"17","author":"HC Abeysinghe","year":"2016","unstructured":"Abeysinghe, H. C., Phillips, E. L., Chin-Cheng, H., Beart, P. M. & Roulston, C. L. Modulating Astrocyte Transition after Stroke to Promote Brain Rescue and Functional Recovery: Emerging Targets Include Rho Kinase. Int J Mol Sci. 17, 288 (2016).","journal-title":"Int J Mol Sci."},{"key":"42933_CR23","doi-asserted-by":"publisher","first-page":"370","DOI":"10.3389\/fphar.2017.00370","volume":"8","author":"S Adesso","year":"2017","unstructured":"Adesso, S. et al. Indoxyl Sulfate Affects Glial Function Increasing Oxidative Stress and Neuroinflammation in Chronic Kidney Disease: Interaction between Astrocytes and Microglia. Front Pharmacol. 8, 370 (2017).","journal-title":"Front Pharmacol."},{"key":"42933_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-6-36","volume":"6","author":"KK Ting","year":"2009","unstructured":"Ting, K. K., Brew, B. J. & Guillemin, G. J. Effect of quinolinic acid on human astrocytes morphology and functions: implications in Alzheimer\u2019s disease. J Neuroinflammation. 6, 36 (2009).","journal-title":"J Neuroinflammation."},{"key":"42933_CR25","doi-asserted-by":"publisher","first-page":"4535","DOI":"10.7150\/thno.25674","volume":"8","author":"S Jiang","year":"2018","unstructured":"Jiang, S. et al. AMPK: Potential Therapeutic Target for Ischemic Stroke. Theranostics. 8, 4535\u20134551 (2018).","journal-title":"Theranostics."},{"key":"42933_CR26","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1159\/000430106","volume":"36","author":"C Li","year":"2015","unstructured":"Li, C. et al. Enhanced M1 and Impaired M2 Macrophage Polarization and Reduced Mitochondrial Biogenesis via Inhibition of AMP Kinase in Chronic Kidney Disease. Cell Physiol Biochem. 36, 358\u2013372 (2015).","journal-title":"Cell Physiol Biochem."},{"key":"42933_CR27","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1097\/00004647-200009000-00002","volume":"20","author":"WD Heiss","year":"2000","unstructured":"Heiss, W. D. Ischemic penumbra: evidence from functional imaging in man. J Cereb Blood Flow Metab. 20, 1276\u20131293 (2000).","journal-title":"J Cereb Blood Flow Metab."},{"key":"42933_CR28","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1038\/jcbfm.2014.130","volume":"34","author":"MK Tobin","year":"2014","unstructured":"Tobin, M. K. et al. Neurogenesis and inflammation after ischemic stroke: what is known and where we go from here. J Cereb Blood Flow Metab. 34, 1573\u20131584 (2014).","journal-title":"J Cereb Blood Flow Metab."},{"key":"42933_CR29","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1038\/nm.3898","volume":"21","author":"LK Smith","year":"2015","unstructured":"Smith, L. K. et al. \u03b22-microglobulin is a systemic pro-aging factor that impairs cognitive function and neurogenesis. Nat Med. 21, 932\u2013937 (2015).","journal-title":"Nat Med."},{"key":"42933_CR30","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s11481-009-9164-4","volume":"4","author":"CA Colton","year":"2009","unstructured":"Colton, C. A. Heterogeneity of microglial activation in the innate immune response in the brain. J Neuroimmune Pharmacol. 4, 399\u2013418 (2009).","journal-title":"J Neuroimmune Pharmacol."},{"key":"42933_CR31","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/j.1460-9568.2004.03498.x","volume":"20","author":"J Malaterre","year":"2004","unstructured":"Malaterre, J. et al. A novel role for polyamines in adult neurogenesis in rodent brain. Eur J Neurosci. 20, 317\u2013330 (2004).","journal-title":"Eur J Neurosci."},{"issue":"1","key":"42933_CR32","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/toxins10010019","volume":"10","author":"Emiko Sato","year":"2017","unstructured":"Sato, E. et al. Impact of the Oral Adsorbent AST-120 on Organ-Specific Accumulation of Uremic Toxins: LC-MS\/MS and MS Imaging Techniques. Toxins (Basel). 10 (2017).","journal-title":"Toxins"},{"key":"42933_CR33","doi-asserted-by":"publisher","first-page":"S77","DOI":"10.1046\/j.1523-1755.2001.59780077.x","volume":"78","author":"PP De Deyn","year":"2001","unstructured":"De Deyn, P. P., D\u2019Hooge, R., Van Bogaert, P. P. & Marescau, B. Endogenous guanidino compounds as uremic neurotoxins. Kidney Int Suppl. 78, S77\u201383 (2001).","journal-title":"Kidney Int Suppl."},{"key":"42933_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.psyneuen.2018.04.019","volume":"94","author":"AM Garrison","year":"2018","unstructured":"Garrison, A. M. et al. Kynurenine pathway metabolic balance influences microglia activity: Targeting kynurenine monooxygenase to dampen neuroinflammation. Psychoneuroendocrinology. 94, 1\u201310 (2018).","journal-title":"Psychoneuroendocrinology."},{"issue":"3","key":"42933_CR35","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3390\/toxins10030124","volume":"10","author":"Takuya Wakamatsu","year":"2018","unstructured":"Wakamatsu, T. et al. Indoxyl Sulfate Promotes Macrophage IL-1\u03b2 Production by Activating Aryl Hydrocarbon Receptor\/NF-\u03ba\/MAPK Cascades, but the NLRP3 inflammasome Was Not Activated. Toxins (Basel). 10 (2018).","journal-title":"Toxins"},{"key":"42933_CR36","doi-asserted-by":"publisher","first-page":"e0149276","DOI":"10.1371\/journal.pone.0149276","volume":"11","author":"C Barisione","year":"2016","unstructured":"Barisione, C. et al. Moderate Increase of Indoxyl Sulfate Promotes Monocyte Transition into Profibrotic Macrophages. PLoS One. 11, e0149276 (2016).","journal-title":"PLoS One."},{"key":"42933_CR37","doi-asserted-by":"publisher","first-page":"5923","DOI":"10.1073\/pnas.94.11.5923","volume":"94","author":"SA Lipton","year":"1997","unstructured":"Lipton, S. A. et al. Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor. Proc Natl Acad Sci USA 94, 5923\u20135928 (1997).","journal-title":"Proc Natl Acad Sci USA"},{"key":"42933_CR38","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1046\/j.1523-1755.2003.00912.x","volume":"63","author":"R D\u2019Hooge","year":"2003","unstructured":"D\u2019Hooge, R. Involvement of voltage- and ligand-gated Ca2\u2009+\u2009channels in the neuroexcitatory and synergistic effects of putative uremic neurotoxins. Kidney Int. 63, 1764\u20131775 (2003).","journal-title":"Kidney Int."},{"key":"42933_CR39","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1161\/CIRCULATIONAHA.108.797407","volume":"119","author":"J Maizel","year":"2009","unstructured":"Maizel, J. et al. Mechanisms of aortic and cardiac dysfunction in uremic mice with aortic calcification. Circulation. 119, 306\u2013313 (2009).","journal-title":"Circulation."},{"key":"42933_CR40","doi-asserted-by":"publisher","first-page":"H1143","DOI":"10.1152\/ajpheart.01237.2010","volume":"301","author":"JM Bugnicourt","year":"2011","unstructured":"Bugnicourt, J. M. et al. Chronic renal failure alters endothelial function in cerebral circulation in mice. Am J Physiol Heart Circ Physiol. 301, H1143\u20131152 (2011).","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"42933_CR41","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/ki.2013.110","volume":"84","author":"J Maizel","year":"2013","unstructured":"Maizel, J. et al. Effects of sevelamer treatment on cardiovascular abnormalities in mice with chronic renal failure. Kidney Int. 84, 491\u2013500 (2013).","journal-title":"Kidney Int."},{"key":"42933_CR42","doi-asserted-by":"publisher","first-page":"e0148503","DOI":"10.1371\/journal.pone.0148503","volume":"11","author":"GP Morris","year":"2016","unstructured":"Morris, G. P. et al. A Comparative Study of Variables Influencing Ischemic Injury in the Longa and Koizumi Methods of Intraluminal Filament Middle Cerebral Artery Occlusion in Mice. PLoS One. 11, e0148503 (2016).","journal-title":"PLoS One."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-42933-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-42933-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-42933-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T09:02:51Z","timestamp":1671267771000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-42933-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,23]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["42933"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-42933-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,23]]},"assertion":[{"value":"10 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"L. H\u00e9naut, M. Grissi, F. Brazier, M. Assem, S. Poirot-Leclercq, G. Savreux-Lenglet, C. Boudot, C. Avondo, A. Boullier, G. Choukroun, J.-M. Chillon and S. Kamel declare no competing interests.\u00a0Z.A. Massy reports grants for CKD REIN and other research projects from Amgen, Baxter, Fresenius Medical Care, GlaxoSmithKline, Merck Sharp and Dohme-Chibret, Sanofi-Genzyme, Lilly, Otsuka and the French government, as well as fees and grants to charities from Amgen, Bayer, and Sanofi-Genzyme. These sources of funding are not necessarily related to the content of the present manuscript. L. H\u00e9naut, M. The results presented in this paper have not been published previously in whole or part, except in abstract format.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"6432"}}